[Clinical studies of the oral and parenteral action of k-strophanthin-alpha in decompensated heart patients].
D000284:Administration, Oral; D000368:Aged; D001835:Body Weight; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D013223:Statistics as Topic; D013328:Strophanthins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced
D013328:Strophanthins
Klinische Untersuchungen über die orale und parenterale Wirksamkeit von k-Strophanthin-alpha an dekompensierten Herzkranken.